Any Day Now

Company formation is the starting point for this long-term program.

Falcon 1 reaches orbit. This establishes launch capability; it is an early enabling milestone, not progress on construction of a Mars base.

Falcon 9 lands its first stage on a droneship. Recovering boosters advances the reusable-launch approach behind the longer-term Mars transport ambition.

The Starship predecessor architecture brought the settlement ambition into a public transportation-system roadmap.

SpaceX begins crewed Dragon flights. Human orbital transport is a precursor capability, distinct from a crewed Starship or a Mars mission.

NASA selects SpaceX to develop its Artemis human landing system. The lunar program creates a funded development path for related Starship capabilities; it is not a Mars landing contract.

SN15 completes its high-altitude flight and landing. The prototype demonstrates the descent maneuver before integrated Super Heavy flights.

The first combined Starship and Super Heavy test lifts off but ends with loss of the vehicle. Integrated testing begins; a successful mission is still ahead.

The FAA closes the first-flight mishap investigation with 63 corrective actions. Closing the investigation alone does not authorize the next launch.

Flight 3 performs an internal cryogenic propellant-transfer test. This is a step toward refueling, not a demonstration of transfer between separate spacecraft.

The fourth integrated test demonstrates return and splashdown capabilities for the ship and booster, moving beyond the earlier loss-of-vehicle outcomes.

The launch tower catches the returning booster for the first time. This advances recovery of the first stage, not full reuse of both stages.

Flight 6 relights one Raptor in space, demonstrating a capability needed for controlled deorbit burns and later orbital operations.

Musk targeted an uncrewed Mars mission for the end of 2026. This was not a base-completion target.

SpaceX reports all major flight objectives met. This is a vehicle-development milestone, not an operational Mars transport service.

Musk prioritized a lunar city and described starting the Mars-city effort in five to seven years.

Flight 13 performs ascent, hot staging and an in-space Raptor relight. Testing continues to build the transport capabilities needed before settlement missions.

Derived from the five-to-seven-year statement in February 2026. A start window, not a completion date.

Derived from the February 2026 estimate of more than twenty years for a Mars city. No firm delivery date.

Musk publicly pledged to build a boring machine and begin tunneling.

A completed demonstration tunnel established a physical prototype, not a citywide transport network.

The company reports the convention-center system opened for an April 2021 event.

The company reports constructing a short Bastrop tunnel to test vacuum-pump systems. This is a test facility, not a passenger Hyperloop service.

TBC reports demonstrating continuous mining and ring assembly with nobody inside the tunnel. A company-reported automation milestone, not independent proof of sustained production speed.

Tennessee and TBC announce Music City Loop, extending the proposed network beyond Nevada. Announcement precedes permitting and construction.

Dubai’s RTA and The Boring Company agree to study a tunnel system. This precedes the later construction agreement and does not itself mean digging has begun.

The company reports its Encore–LVCC connector opened in 2025. This adds another working connection beyond the original convention-center loop.

The February report says Prufrock-MB1 is installed and ready while permitting is being finalized. Site readiness is separate from authorization to mine.

TBC reports receiving its TDOT tunnel permit and starting tunneling the same day. This is the first hard-rock construction step, not passenger operations.

A definitive agreement sets out a 6.4-km, four-station pilot. The company describes design, permitting and mobilization steps before tunneling.

TBC reports two Prufrock machines mining simultaneously in Nashville. Parallel operation is an important scaling test for the hard-rock program.

TBC reports automated placement of a six-segment tunnel ring in under a minute. This is a ring-building claim, not an overall tunnel advance rate.

The company announces financing for hiring, Loop expansion and Prufrock development. Funding increases capacity to pursue the mission; it does not demonstrate delivery.

As reviewed in October 2026: one mile per week and under $5 million per mile. These are company targets, not independently measured results or newly announced deadlines.

The October 1 update targets a late-October MB3 launch. This marker is the target month, not a completed launch; it was still ahead at the October 15 review.

TBC aims to have four machines underground in Nashville before year end. This is a construction-capacity target, not the opening date of passenger service.

Founding is the timeline baseline. Musk joined as an investor in 2004; company founding is not attributed to him here.

The staged vehicle strategy begins with a sports car and moves toward more affordable electric vehicles.

Tesla begins regular Roadster production, giving the first master plan its initial commercial vehicle. A high-price sports car is the first stage of the proposed affordability ladder.

Model S customer deliveries begin. The sedan broadens Tesla’s product range beyond the Roadster and advances the staged vehicle plan.

Tesla introduces its fast-charging network. Charging infrastructure tackles a practical barrier to longer-distance electric driving.

Tesla dates the first Powerwall installation to May 2015. Home storage becomes a concrete product alongside the electric-vehicle business.

The second plan adds integrated solar and storage, more vehicle segments, autonomy and an owner-operated shared fleet. These are stated goals, not proof of their delivery.

Tesla completes the SolarCity acquisition, bringing solar generation into the company alongside vehicles and batteries. This gives the broader energy mission an operating solar business.

The mission broadens from sustainable transport to sustainable energy, encompassing generation and storage. The wording is documented in subsequent Tesla filings.

Deliveries begin for the lower-priced sedan designed for the mass market. Initial delivery is distinct from reaching sustained high-volume output.

Tesla’s product history dates Powerwall mass production at Giga Nevada to 2017, expanding the manufacturing base for home energy storage.

Tesla introduces the larger Megapack storage product for utility-scale applications. The energy mission now includes a dedicated large-project battery platform.

Tesla begins early production and deliveries of its commercial electric truck, extending the vehicle mission into heavy freight.

Tesla previews a humanoid robot. Robotics becomes a visible development program, but a prototype demonstration does not establish a commercially deployable workforce.

Master Plan Part 3 lays out a pathway to a sustainable global energy economy. Publication is not completion of that transition.

A small fleet begins taking paying passengers in Austin. This limited rollout is distinct from the broad shared-fleet vision in Part Deux.

Master Plan IV puts AI, robotics, mobility and energy together under sustainable abundance.

Musk announced a wording change in December. Tesla’s current master-plans page uses amazing abundance.

Tesla reports installation of its millionth Powerwall. This is a deployment-scale milestone, not a claim that the wider energy transition is complete.

Reuters reports expansion remained limited after earlier geographic targets, with executives taking a more cautious tone. Deployment scope still matters when judging the autonomy mission.

The company begins developing brain-computer interfaces.

Tim Urban’s Neuralink explainer, drawing on interviews with Musk and the team, connects medical applications with the longer-term aim of human–AI integration. These are parallel ambitions, not completed stages.

Neuralink publishes its multichannel interface research, including flexible threads and robotic insertion. The paper describes a research platform, not an approved human treatment.

Neuralink demonstrates a monkey controlling a game through decoded neural activity. This is a preclinical demonstration, separate from human safety and efficacy evidence.

Neuralink opens a registry for people interested in future trials. Registry enrollment is not implantation or admission to a clinical study.

Neuralink describes a long-term goal of a general input/output interface for the brain. Its near-term clinical work has a narrower scope.

Neuralink reports FDA authorization to begin its first human clinical study. This is not general commercial approval.

PRIME begins recruiting participants to evaluate implant and robot safety and initial device-control functionality.

The first participant receives the investigational implant.

Neuralink reports its first participant using the system for computer applications and games. This dated update documents functional use after the January implant.

Neuralink reports that some threads retracted after the first surgery, reducing effective electrodes. This exposes a durability challenge even as software adjustments support continued use.

The August 21 update says Alex received the implant the previous month and began using CAD software. The chart uses July for the procedure, not the report’s publication date.

Neuralink announces FDA Breakthrough Device Designation for its vision program. The designation is not marketing approval or evidence that vision restoration has been achieved.

Health Canada authorizes CAN-PRIME, Neuralink’s first international trial. The announcement opens recruitment; it does not establish completion of the study.

Neuralink announces a feasibility study extending implant control to an investigational assistive robotic arm. The medical track expands beyond computer interaction.

The one-year update describes three people with paralysis using implants in daily life. This is early participant experience, not evidence of universal benefit.

Neuralink announces FDA Breakthrough Device Designation for a communication-restoration device. This identifies another development pathway, without establishing marketing approval.

Neuralink’s funding announcement pairs expanding patient access with developing future devices that deepen the connection between biological and artificial intelligence. It does not announce a completion date for that broader goal.

Neuralink announces approvals and recruitment for GB-PRIME across two sites in Great Britain, expanding the clinical research network.

Neuralink’s two-year update reports 21 participants. This expands the clinical experience base, without establishing broad availability or completion of either mission.